ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test

By Sahil Pandey June 24 (Reuters) - ALZpath said on Wednesday it had signed a global licensing agreement with Abbott ...
Nasdaq

Abbott (ABT) Gets FDA Nod for Alinity I Laboratory Test

Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for the Alinity i laboratory traumatic brain injury (TBI) blood test. This will be the first commercially available TBI ...
The Business Journals

Abbott Labs performing well despite huge drop-off in Covid test sales

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The North Chicago company said ...
Forbes

Abbott Labs Reports $1 Billion Profit Despite Falling Covid Test Sales

The Abbott Laboratories logo is displayed at the company's booth during the Consumer Electronics Show (CES) on January 5, 2022 in Las Vegas, Nevada. (Photo by Patrick T. FALLON / AFP) (Photo by ...
Chicago Tribune

Abbott’s COVID-19 test sales dive by nearly 90%

Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on ...
FierceBiotech

Abbott's lab-based blood test for concussion scores FDA nod

Abbott's lab-based concussion test looks for two biomarkers in the blood, both of which have been closely linked to traumatic brain injuries when found in elevated concentrations. In studies, it was ...
Investopedia

Abbott Laboratories Posts Big Drop in COVID-19 Testing Revenue

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
Benzinga.com

Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall

On Wednesday, Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion. Organic sales growth for the underlying ...
The Motley Fool

Is Abbott Laboratories Stock a Buy Now?

On Jan. 24, Abbott posted its year-end and fourth-quarter numbers for the last three months of 2023. Revenue in Q4 rose by 1.5% year over year to $10.2 billion, but on an organic basis and when ...
CNBC

Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales

Shares of Abbott Laboratories popped after the company's earnings and revenue topped Wall Street estimates, defying a dramatic slowdown in sales of its Covid tests. The results were driven in part to ...
MarketWatch

Abbott Labs stock soars 8% after earnings beat as people refocus on their health in a post-COVID world

Abbott Laboratories stock rose 8% Wednesday and was the second biggest gainer on the S&P 500 index, after the diagnostics and medical-device company beat earnings estimates for the first quarter. As ...